Table 6.
Outcome of COVID-19 infection versus underlying comorbidities*
| Home | Hospital | Number pos | Rate | HR | 95% CI | P | |
| Total | |||||||
| DM | 9 | 2 | 11 | 11.46% | 1.19 | 0.308-4.585 | >0.10 |
| no DM | 72 | 13 | 85 | ||||
| HTN | 14 | 5 | 19 | 19.79% | 2.03 | 0.784-5.234 | >0.10 |
| no HTN | 67 | 10 | 77 | ||||
| COPD | 12 | 3 | 15 | 15.63% | 1.35 | 0.432-4.217 | >0.10 |
| no COPD | 69 | 12 | 81 | ||||
| Heart disease | 8 | 5 | 13 | 13.54% | 3.19 | 1.297-7.855 | 0.0115 |
| no heart disease | 73 | 10 | 83 | ||||
| Any feature | 35 | 7 | 42 | 43.75% | 1.12 | 0.444-2.854 | >0.10 |
| No feature | 46 | 8 | 54 |
DM: diabetes mellitus; HTN: hypertension; COPD: chronic obstructive pulmonary disease; HR hazard ratio.
*Summary data from UC/AMC, FSR, and Dutch